Retirement (Rücknahme) von 150 Mill. Aktien. Vom Penny zum Dollar!!! - 500 Beiträge pro Seite
eröffnet am 14.02.12 20:14:32 von
neuester Beitrag 14.02.12 20:37:50 von
neuester Beitrag 14.02.12 20:37:50 von
Beiträge: 4
ID: 1.172.416
ID: 1.172.416
Aufrufe heute: 0
Gesamt: 445
Gesamt: 445
Aktive User: 0
ISIN: US8343715020 · WKN: A140Z6
0,0037
USD
-2,63 %
-0,0001 USD
Letzter Kurs 01.12.20 Nasdaq OTC
Neuigkeiten
02.04.24 · Accesswire  |
31.10.23 · Accesswire |
19.10.23 · Accesswire |
08.06.23 · Accesswire |
Feedback
HAMMERNEWS MUST READ
Solos Endoscopy, Inc. Announces Retirement of 150 Million Common Shares
BOSTON, Feb. 14, 2012 /PRNewswire via COMTEX/ -- Solos Endoscopy, Inc. (OTCPK: SNDY) announced today that the Company's Board of Directors has completed the retirement of one hundred fifty million (150,000,000) common shares held by its officers and directors in exchange for Series B Convertible Preferred Shares. The common shares held by the officers and directors have now been cancelled and returned back to the Company treasury. This transaction represents a reduction of approximately 22% of the Company's issued and outstanding common shares.
The retirement of common shares by the Company's officers and directors will allow for greater flexibility to utilize the assets of Solos for debt reduction, future financing, and services. The Company intends to use proceeds from future financing for the development of new instrument lines as well as further enhancements to its MammoView? instrument line.
Solos Endoscopy, Inc. Announces Retirement of 150 Million Common Shares
BOSTON, Feb. 14, 2012 /PRNewswire via COMTEX/ -- Solos Endoscopy, Inc. (OTCPK: SNDY) announced today that the Company's Board of Directors has completed the retirement of one hundred fifty million (150,000,000) common shares held by its officers and directors in exchange for Series B Convertible Preferred Shares. The common shares held by the officers and directors have now been cancelled and returned back to the Company treasury. This transaction represents a reduction of approximately 22% of the Company's issued and outstanding common shares.
The retirement of common shares by the Company's officers and directors will allow for greater flexibility to utilize the assets of Solos for debt reduction, future financing, and services. The Company intends to use proceeds from future financing for the development of new instrument lines as well as further enhancements to its MammoView? instrument line.
Hier findet ihr alles Wissenswertes um Solos Endoscopy, Börse USA:
http://investorshub.advfn.com/boards/board.aspx?board_id=820…
http://investorshub.advfn.com/boards/board.aspx?board_id=820…
Antwort auf Beitrag Nr.: 42.750.430 von workstock am 14.02.12 20:25:56Was istjetzt los ?
Sellerie on good News oder was läuft hier jetzt ab ?
Sellerie on good News oder was läuft hier jetzt ab ?
DurchsuchenBeitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Investoren beobachten auch:
| Wertpapier | Perf. % |
|---|---|
| +2,63 | |
| +5,36 | |
| +0,62 | |
| 0,00 | |
| +0,17 | |
| +0,60 | |
| +29.900,00 | |
| +1,17 | |
| 0,00 | |
| -99,00 |
Meistdiskutiert
| Wertpapier | Beiträge | |
|---|---|---|
| 134 | ||
| 82 | ||
| 49 | ||
| 33 | ||
| 28 | ||
| 27 | ||
| 26 | ||
| 14 | ||
| 13 | ||
| 11 |
